Solid Biosciences Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Welcome, everyone, to the 40th Annual JPMorgan Healthcare Conference. My name is Anupam Rama. I'm one of the senior biotech analyst here at JPMorgan. I'm joined by (inaudible),Carol Smith, Malcomcuno and Priyanka Grover from the team. Our next presenting company is Solid Bio. Representing on behalf of the company, we have CEO, Ilan Ganot. (Operator Instructions) With that Ilan, take it away.
Thanks, everybody, for joining today. Thanks, JPMorgan. Thank you, Anupam, for hosting us. I'm excited to review solid progress in 2021 and discuss our key priorities for 2020. We'll also share some new technologies that we're excited about and have been working on to help improve the lives of patients.
On Slide 2, please note that we will be sharing some forward-looking statements, and I highly recommend a thorough read right after we wrap up. On Slide 3, we're looking at a quick history of the company. As many of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
